Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Vertex Pharmaceuticals Inc. buy UBS Group AG

Vertex Pharmaceuticals Inc.
Start price
€459.85
05.11.24 / 50%
Target price
€536.01
05.11.25
Performance (%)
-21.69%
End price
€360.10
06.11.25
Summary
This prediction ended on 06.11.25 with a price of €360.10. The price of Vertex Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.69%. UBS_Group_AG has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Vertex Pharmaceuticals Inc. -0.501% -0.501% 36.610%
iShares Core DAX® -0.874% 5.325% 6.865%
iShares Nasdaq 100 -0.381% 1.979% 25.696%
iShares Nikkei 225® -1.676% 1.952% 41.443%
iShares S&P 500 -0.655% 2.069% 21.405%

Comments by UBS_Group_AG for this prediction

In the thread Trading Vertex Pharmaceuticals Inc.
Prediction Buy
Perf. (%) -21.69%
Target price 536.014
Change
Ends at 05.11.25

Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten

UBS Group AG 
0
Report Share
06.11.25
In the thread Vertex Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -21.69%
Target price 536.014
Change
Ends at 05.11.25

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at UBS Group AG from $562.00 to $586.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat

UBS Group AG 
0
Report Share
05.11.24

Current prediction by UBS_Group_AG for Vertex Pharmaceuticals Inc.

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€352.60
07.11.25
€473.22
07.11.26
32.93%
18:23

UBS Group AG 
07.11.25 50%

Stopped prediction by UBS_Group_AG for Vertex Pharmaceuticals Inc.

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€423.50
13.07.26
-
13.07.27
10.67%
18:23

UBS Group AG 
13.07.26 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€398.35
26.01.26
-
26.01.27
17.66%
18:23

UBS Group AG 
26.01.26 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€379.15
09.12.25
-
09.12.26
23.62%
18:23

UBS Group AG 
09.12.25 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€344.35
05.08.25
€478.40
05.08.26
21.97%
06.08.26

UBS Group AG 
05.08.25 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€459.95
17.10.24
€519.06
17.10.25
-21.84%
18.10.25

UBS Group AG 
17.10.24 50%